minimal residual disease
Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
Treatment of <span class="disease" id="14654953-0-13-37">minimal residual disease</span> after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and <span class="gene" id="14654953-0-151-157">GM-CSF</span>.